A Comparison of FineVision Intraocular Lenses vs Symfony Intraocular Lenses
Launched by BEAVER-VISITEC INTERNATIONAL, INC. · Jun 3, 2019
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
With the advent of a new intraocular lens (IOL) materials, technologies and advanced optics, higher spectacle independence after surgery is now possible.
Multifocal IOLs work by splitting light into different foci, which is known to generate photic effects. Trifocal optics, which have been available on the European market since 2010, offer spectacle independence in most cases. Typically, visual acuity is maintained throughout the whole range of vision from distance to near vision, and general patient satisfaction has proven that trifocal IOLs are well tolerated by patients.
Patients havin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Cataract patients requesting independence from spectacles
- • 2. Potential visual acuity of 0.0 logMar
- Exclusion Criteria:
- • 1. Unrealistic expectations (sharp clear vision is the main concern of the patient)
- • 2. Ocular pathology besides cataract (glaucoma, macular degeneration, retinopathies, corneal opacities, corneal guttata.. etc.)
- • 3. Previous refractive surgery
- • 4. Expected pathology after surgery (p.e. uveitis, diabetic retinopathy, PEX)
- • 5. Preoperative corneal astigmatism of \> 1.0 D
- • 6. Any intraocular or postoperative complication
- • 7. Dry eye disease
- • 8. History of ocular trauma
About Beaver Visitec International, Inc.
Beaver-Visitec International, Inc. is a leading global medical device company specializing in innovative surgical solutions for ophthalmic and other medical specialties. With a commitment to advancing patient care, the company focuses on developing high-quality, innovative products that enhance surgical precision and improve clinical outcomes. Leveraging extensive research and development expertise, Beaver-Visitec collaborates with healthcare professionals to address unmet needs in the operating room, thereby transforming surgical practices and enhancing patient safety. Through its dedication to excellence and innovation, Beaver-Visitec continues to play a pivotal role in the evolution of surgical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Mohammed H. F. Ghoneem, MD
Principal Investigator
Department of Ophthalmology, Faculty of Medicine, University of Alexandria,
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials